Safety profile and causes of withdrawal due to adverse events in systemic lupus erythematosus patients treated long-term with cyclosporine A

Lupus

Volumn 9, Issue 9, 2000, Pages 676-680

  Conti, F ^a   Priori, R ^a   Alessandri, C ^a   Spinelli, F R ^a   Medda, E ^a   Valesini, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adverse events; Cyclosporine A; Safety profile; Systemic lupus erythematosus

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; AGING; ARTICLE; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; HEADACHE; HUMAN; HYPERTENSION; HYPERTRICHOSIS; INSOMNIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PARESTHESIA; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; TREMOR; VERTIGO;

ADOLESCENT; ADULT; CHILD; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0034534077     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300676096627     Document Type: Article

References (22)

1. Immunomodulators: Immunosuppressive agents and immunostimulants
2. The optimal use of Cyclosporine A in autoimmune disease
3. Immunosuppressive therapy in the treatment of autoimmune disease
4. Cyclosporin in the treatment of lupus nephritis
5. Long term treatment of systemic lupus erythematosus with cyclosporine A
6. The effects of cyclosporine in patients with systemic lupus
7. Effect of low dose cyclosporine A in association with corticosteroids vs corticosteroids alone on SLE disease activity: 12-month results of a randomized pilot study
8. Cyclosporine A in the treatment of systemic lupus erythematosus: Results of an open clinical study
9. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: A pilot study
10. Predictive value of cyclosporine A levels for efficacy on renal dysfunction in psoriasis
11. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporin
12. The 1982 revised criteria for the classification of systemic lupus erythematosus
13. Therapy with cyclosporine in psoriatic arthritis
14. Cyclosporin in rheumatoid arthritis
15. Cyclosporin relieves arthralgia, causes angioedema
16. Cyclosporine A for treatment of systemic lupus erythematosus
17. Open therapeutic trial of cyclosporin in systemic lupus erythematosus. Preliminary results in four patients
18. Effects of cyclosporin in severe systemic lupus erythematosus
19. The place of cyclosporine A in the treatment of connective tissue disease
20. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporine A
21. Effect of low-dose cyclosporine A on systemic lupus erythematosus disease activity
22. Cyclosporine treatment of lupus membranous nephropathy